198 related articles for article (PubMed ID: 15002758)
1. Clinical value of vasodilator test with inhaled nitric oxide for predicting long-term response to oral vasodilators in pulmonary hypertension.
Morales-Blanhir J; Santos S; de Jover L; Sala E; Paré C; Roca J; Rodriguez-Roisin R; Barberà JA
Respir Med; 2004 Mar; 98(3):225-34. PubMed ID: 15002758
[TBL] [Abstract][Full Text] [Related]
2. Acute and chronic effects of sildenafil in patients with pulmonary arterial hypertension.
Preston IR; Klinger JR; Houtches J; Nelson D; Farber HW; Hill NS
Respir Med; 2005 Dec; 99(12):1501-10. PubMed ID: 15890512
[TBL] [Abstract][Full Text] [Related]
3. Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide.
Michelakis E; Tymchak W; Lien D; Webster L; Hashimoto K; Archer S
Circulation; 2002 May; 105(20):2398-403. PubMed ID: 12021227
[TBL] [Abstract][Full Text] [Related]
4. Inhaled nitric oxide versus intravenous vasodilators in severe pulmonary hypertension after cardiac surgery.
Schmid ER; Bürki C; Engel MH; Schmidlin D; Tornic M; Seifert B
Anesth Analg; 1999 Nov; 89(5):1108-15. PubMed ID: 10553820
[TBL] [Abstract][Full Text] [Related]
5. Combination of inhaled nitric oxide and intravenous prostacyclin for successful treatment of severe pulmonary hypertension in a patient with acute respiratory distress syndrome.
Kuhlen R; Walbert E; Fränkel P; Thaden S; Behrendt W; Rossaint R
Intensive Care Med; 1999 Jul; 25(7):752-4. PubMed ID: 10470582
[TBL] [Abstract][Full Text] [Related]
6. Vasoresponsiveness of sarcoidosis-associated pulmonary hypertension.
Preston IR; Klinger JR; Landzberg MJ; Houtchens J; Nelson D; Hill NS
Chest; 2001 Sep; 120(3):866-72. PubMed ID: 11555522
[TBL] [Abstract][Full Text] [Related]
7. A Comparison of Inhaled Nitric Oxide Versus Inhaled Epoprostenol for Acute Pulmonary Hypertension Following Cardiac Surgery.
McGinn K; Reichert M
Ann Pharmacother; 2016 Jan; 50(1):22-6. PubMed ID: 26438636
[TBL] [Abstract][Full Text] [Related]
8. Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease: vasodilator capacity and cellular mechanisms.
Rimensberger PC; Spahr-Schopfer I; Berner M; Jaeggi E; Kalangos A; Friedli B; Beghetti M
Circulation; 2001 Jan; 103(4):544-8. PubMed ID: 11157720
[TBL] [Abstract][Full Text] [Related]
9. Inhaled prostacyclin following surgical repair of congenital heart disease--a pilot study.
Carroll CL; Backer CL; Mavroudis C; Cook K; Goodman DM
J Card Surg; 2005; 20(5):436-9. PubMed ID: 16153274
[TBL] [Abstract][Full Text] [Related]
10. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
Kieler-Jensen N; Lundin S; Ricksten SE
J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic response to sildenafil, nitric oxide, and iloprost in primary pulmonary hypertension.
Leuchte HH; Schwaiblmair M; Baumgartner RA; Neurohr CF; Kolbe T; Behr J
Chest; 2004 Feb; 125(2):580-6. PubMed ID: 14769741
[TBL] [Abstract][Full Text] [Related]
12. Intravenous prostacyclin mitigates inhaled nitric oxide rebound effect: A case control study.
Hermon M; Golej J; Burda G; Marx M; Trittenwein G; Pollak A
Artif Organs; 1999 Nov; 23(11):975-8. PubMed ID: 10564300
[TBL] [Abstract][Full Text] [Related]
13. Effects of dipyridamole and inhaled nitric oxide in pediatric patients with pulmonary hypertension.
Ziegler JW; Ivy DD; Wiggins JW; Kinsella JP; Clarke WR; Abman SH
Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1388-95. PubMed ID: 9817684
[TBL] [Abstract][Full Text] [Related]
14. Treatment of pulmonary hypertension in patients undergoing cardiac surgery with cardiopulmonary bypass: a randomized, prospective, double-blind study.
Fattouch K; Sbraga F; Sampognaro R; Bianco G; Gucciardo M; Lavalle C; Vizza CD; Fedele F; Ruvolo G
J Cardiovasc Med (Hagerstown); 2006 Feb; 7(2):119-23. PubMed ID: 16645371
[TBL] [Abstract][Full Text] [Related]
15. Inhaled nitric oxide combined with prostacyclin and adrenomedullin in acute respiratory failure with pulmonary hypertension in piglets.
Dani C; Pavoni V; Corsini I; Longini M; Gori G; Giannesello L; Perna A; Gritti G; Paternostro F; Forestieri A; Buonocore G; Rubaltelli FF
Pediatr Pulmonol; 2007 Nov; 42(11):1048-56. PubMed ID: 17902148
[TBL] [Abstract][Full Text] [Related]
16. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].
Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbrück B; Grimminger F; Seeger W
Pneumologie; 2000 Mar; 54(3):133-42. PubMed ID: 10783653
[TBL] [Abstract][Full Text] [Related]
17. Contribution of pulmonary surfactant with inhaled nitric oxide for treatment of pulmonary hypertension.
Kusuda S; Kim TJ; Koriyama T; Matsunami S; Nakanishi H
Pediatr Int; 2006 Oct; 48(5):459-63. PubMed ID: 16970783
[TBL] [Abstract][Full Text] [Related]
18. Effects of inhaled versus intravenous vasodilators in experimental pulmonary hypertension.
Walmrath D; Schermuly R; Pilch J; Grimminger F; Seeger W
Eur Respir J; 1997 May; 10(5):1084-92. PubMed ID: 9163651
[TBL] [Abstract][Full Text] [Related]
19. Aerosolized prostacyclin and iloprost in severe pulmonary hypertension.
Olschewski H; Walmrath D; Schermuly R; Ghofrani A; Grimminger F; Seeger W
Ann Intern Med; 1996 May; 124(9):820-4. PubMed ID: 8610951
[TBL] [Abstract][Full Text] [Related]
20. Additive effects of inhaled nitric oxide and intravenous milrinone in experimental pulmonary hypertension.
Deb B; Bradford K; Pearl RG
Crit Care Med; 2000 Mar; 28(3):795-9. PubMed ID: 10752832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
